ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 2056

$492K Total Retail Price of All Prescriptions

Rank: 80 out of 2056

458 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

9% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 448 439 1 2
LEVOTHYROXINE SODIUM 436 436 2 3
LISINOPRIL 422 393 3 1
HYDROCHLOROTHIAZIDE 342 341 4 7
PRAVASTATIN SODIUM 325 291 5 20
OMEPRAZOLE 255 241 6 4
WARFARIN SODIUM 233 233 7 12
ATORVASTATIN CALCIUM 207 199 8 17
AMLODIPINE BESYLATE 203 190 9 6
ZOLPIDEM TARTRATE 197 183 10 23
METOPROLOL SUCCINATE 189 185 11 19
DONEPEZIL HCL 159 159 12 37
METFORMIN HCL 155 136 13 8
METOPROLOL TARTRATE 136 124 14 11
FUROSEMIDE 134 122 15 9
HYDROCODONE-ACETAMINOPHEN 132 124 S3 16 5
CRESTOR 130 129 17 30
TAMSULOSIN HCL 129 116 18 28
ATENOLOL 119 119 19 10
LOSARTAN POTASSIUM 119 115 19 13
CITALOPRAM HBR 114 114 21 15
FLUTICASONE PROPIONATE 105 100 22 31
RANITIDINE HCL 100 98 23 22
POTASSIUM CHLORIDE 99 99 24 18
DICLOFENAC SODIUM 85 83 25 95
FLUOXETINE HCL 84 70 26 33
ALLOPURINOL 82 80 27 32
NAMENDA 77 77 28 62
GABAPENTIN 72 64 29 14
CLOPIDOGREL 71 71 30 72
PANTOPRAZOLE SODIUM 70 58 31 55
DOXEPIN HCL 70 70 31 200
TRIAMTERENE-HCTZ 68 68 33 46
TRAMADOL HCL 66 58 34 27
AZITHROMYCIN 64 61 35 54
TRAZODONE HCL 62 49 36 21
MIRTAZAPINE 57 57 37 45
DILTIAZEM 24HR CD 52 52 38 120
DIOVAN 51 51 39 68
METHOCARBAMOL 50 45 R 40 65
CYMBALTA 50 42 40 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.